|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0321759
|
|
|
PWS
|
[NCBI]
|
0.0024141
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.00225406
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.00225406
|
|
|
SHBG
|
[NCBI]
|
0.00195122
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.00150144
|
|
|
obesity
|
[NCBI]
|
0.00132063
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00123628
|
|
|
PCOS1
|
[NCBI]
|
0.00107897
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000978597
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000869044
|
|
|
body mass index quantitative trait locus on chromosome 20, in children
|
[NCBI]
|
0.000750092
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000750092
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.000750092
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.000750092
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.000750092
|
|
|
body mass index quantitative trait locus on chromosome 16, in children
|
[NCBI]
|
0.000750092
|
|
|
CF
|
[NCBI]
|
0.000717111
|
|
|
body mass index
|
[NCBI]
|
0.000594776
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000488694
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000488694
|
|
|
LEP
|
[NCBI]
|
0.000464823
|
|
|
acanthosis nigricans
|
[NCBI]
|
0.000392409
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.000392409
|
|
|
LEPR
|
[NCBI]
|
0.000341872
|
|
|
OB10P
|
[NCBI]
|
0.000331221
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000331221
|
|
|
NIDDM
|
[NCBI]
|
0.000330351
|
|
|
LPL
|
[NCBI]
|
0.000324711
|
|
|
torus palatinus and torus mandibularis
|
[NCBI]
|
0.000286701
|
|
|
SLE
|
[NCBI]
|
0.000282014
|
|
|
APOB
|
[NCBI]
|
0.000271271
|
|
|
NIDDM2
|
[NCBI]
|
0.000252
|
|
|
INS
|
[NCBI]
|
0.000235439
|
|
|
BMND3
|
[NCBI]
|
0.000223787
|
|
|
EGF
|
[NCBI]
|
0.000211065
|
|
|
ADIPOQ
|
[NCBI]
|
0.000189915
|
|
|
FABP2
|
[NCBI]
|
0.000189261
|
|
|
PPARG
|
[NCBI]
|
0.000187877
|
|
|
abdominal body fat distribution
|
[NCBI]
|
0.000178981
|
|
|
PTH
|
[NCBI]
|
0.000167508
|
|
|
INSIG2
|
[NCBI]
|
0.000153507
|
|
|
osteoporosis
|
[NCBI]
|
0.000146512
|
|
|
PEE1
|
[NCBI]
|
0.000132931
|
|
|
GBD1
|
[NCBI]
|
0.000117605
|
|
|
MDD
|
[NCBI]
|
0.000113372
|
|
|
hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial
|
[NCBI]
|
0.000108544
|
|
|
UCP1
|
[NCBI]
|
9.95244e-05
|
|
|
MC4R
|
[NCBI]
|
9.52984e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
9.51151e-05
|
|
|
PLTP
|
[NCBI]
|
9.32538e-05
|
|
|
RBP4
|
[NCBI]
|
8.3494e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
8.08587e-05
|
|
|
CD
|
[NCBI]
|
8.00851e-05
|
|
|
ATHS
|
[NCBI]
|
7.62148e-05
|
|
|
IS1
|
[NCBI]
|
7.39674e-05
|
|
|
RETN
|
[NCBI]
|
7.31215e-05
|
|
|
ADRB3
|
[NCBI]
|
7.31215e-05
|
|
|
MODY8
|
[NCBI]
|
7.04645e-05
|
|
|
PBEF1
|
[NCBI]
|
6.52688e-05
|
|
|
resting heart rate
|
[NCBI]
|
6.37458e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
6.37458e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
6.37458e-05
|
|
|
GCCR
|
[NCBI]
|
6.01336e-05
|
|
|
TH
|
[NCBI]
|
5.87094e-05
|
|
|
GHRL
|
[NCBI]
|
5.765e-05
|
|
|
FPLD3
|
[NCBI]
|
5.48274e-05
|
|
|
thrombophilia
|
[NCBI]
|
5.48274e-05
|
|
|
HOA
|
[NCBI]
|
5.48274e-05
|
|
|
PYY
|
[NCBI]
|
5.47581e-05
|
|
|
NPY
|
[NCBI]
|
5.28607e-05
|
|
|
GFAP
|
[NCBI]
|
5.20657e-05
|
|
|
endometrial cancer
|
[NCBI]
|
5.15616e-05
|
|
|
GNB3
|
[NCBI]
|
5.13069e-05
|
|
|
PPARA
|
[NCBI]
|
5.03344e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
4.87787e-05
|
|
|
PCNA
|
[NCBI]
|
4.81604e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
4.7267e-05
|
|
|
SELP
|
[NCBI]
|
4.66871e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
4.63567e-05
|
|
|
VIP
|
[NCBI]
|
4.38195e-05
|
|
|
MG
|
[NCBI]
|
4.34999e-05
|
|
|
UCP2
|
[NCBI]
|
4.3459e-05
|
|
|
VDR
|
[NCBI]
|
4.26111e-05
|
|
|
hypertension, essential
|
[NCBI]
|
4.22319e-05
|
|
|
FTO
|
[NCBI]
|
4.13351e-05
|
|
|
ENPP1
|
[NCBI]
|
3.95566e-05
|
|
|
POMC
|
[NCBI]
|
3.84631e-05
|
|
|
EPO
|
[NCBI]
|
3.80119e-05
|
|
|
UCP3
|
[NCBI]
|
3.69125e-05
|
|
|
ADRB2
|
[NCBI]
|
3.66686e-05
|
|
|
TNF
|
[NCBI]
|
3.64896e-05
|
|
|
CFTD
|
[NCBI]
|
3.61828e-05
|
|
|
NPPB
|
[NCBI]
|
3.53131e-05
|
|
|
HK2
|
[NCBI]
|
3.53131e-05
|
|
|
HGF
|
[NCBI]
|
3.43838e-05
|
|
|
SERPINA6
|
[NCBI]
|
3.42439e-05
|
|
|
LMNA
|
[NCBI]
|
3.37195e-05
|
|
|
TCF7L2
|
[NCBI]
|
3.31241e-05
|
|
|
obesity, susceptibility to, on chromosome 10q
|
[NCBI]
|
3.30647e-05
|
|
|
AGT
|
[NCBI]
|
3.11381e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
3.06903e-05
|
|
|
PLIN
|
[NCBI]
|
2.98462e-05
|
|
|
IGFALS
|
[NCBI]
|
2.87491e-05
|
|
|
VEGF
|
[NCBI]
|
2.86899e-05
|
|
|
MADA
|
[NCBI]
|
2.80897e-05
|
|
|
TGD
|
[NCBI]
|
2.80897e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
2.80259e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.79627e-05
|
|
|
MODY
|
[NCBI]
|
2.79455e-05
|
|
|
glycogen storage disease ib
|
[NCBI]
|
2.73073e-05
|
|
|
CFTR
|
[NCBI]
|
2.62604e-05
|
|
|
osteoarthritis
|
[NCBI]
|
2.58487e-05
|
|
|
ALMS
|
[NCBI]
|
2.58487e-05
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
2.50244e-05
|
|
|
ENDOGL1
|
[NCBI]
|
2.48401e-05
|
|
|
APOE
|
[NCBI]
|
2.44939e-05
|
|
|
CRH
|
[NCBI]
|
2.40561e-05
|
|
|
GIP
|
[NCBI]
|
2.40523e-05
|
|
|
CTSK
|
[NCBI]
|
2.38677e-05
|
|
|
NPPA
|
[NCBI]
|
2.30947e-05
|
|
|
AFP
|
[NCBI]
|
2.26796e-05
|
|
|
IRS2
|
[NCBI]
|
2.23151e-05
|
|
|
FCHL
|
[NCBI]
|
2.21486e-05
|
|
|
HNF1A
|
[NCBI]
|
2.20899e-05
|
|
|
PYY2
|
[NCBI]
|
2.175e-05
|
|
|
ALB
|
[NCBI]
|
2.11465e-05
|
|
|
CMD1A
|
[NCBI]
|
2.10932e-05
|
|
|
GH1
|
[NCBI]
|
2.0808e-05
|
|
|
CPB2
|
[NCBI]
|
1.99205e-05
|
|
|
KLK3
|
[NCBI]
|
1.98179e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.97514e-05
|
|
|
GPR39
|
[NCBI]
|
1.97514e-05
|
|
|
CDG1A
|
[NCBI]
|
1.96418e-05
|
|
|
COH1
|
[NCBI]
|
1.96418e-05
|
|
|
AGTR1
|
[NCBI]
|
1.9488e-05
|
|
|
FAAH
|
[NCBI]
|
1.90091e-05
|
|
|
CCK
|
[NCBI]
|
1.87405e-05
|
|
|
NPY2R
|
[NCBI]
|
1.82712e-05
|
|
|
ADRA2B
|
[NCBI]
|
1.82712e-05
|
|
|
GRB14
|
[NCBI]
|
1.82712e-05
|
|
|
GPD1
|
[NCBI]
|
1.82712e-05
|
|
|
ACE
|
[NCBI]
|
1.76968e-05
|
|
|
CCND1
|
[NCBI]
|
1.74515e-05
|
|
|
GPRK2L
|
[NCBI]
|
1.70962e-05
|
|
|
MPO
|
[NCBI]
|
1.67839e-05
|
|
|
CAT
|
[NCBI]
|
1.67125e-05
|
|
|
PPARGC1B
|
[NCBI]
|
1.6123e-05
|
|
|
IGF2
|
[NCBI]
|
1.52991e-05
|
|
|
SEPN1
|
[NCBI]
|
1.52931e-05
|
|
|
SRD5A1
|
[NCBI]
|
1.52931e-05
|
|
|
SLC27A4
|
[NCBI]
|
1.52931e-05
|
|
|
IGF1
|
[NCBI]
|
1.49483e-05
|
|
|
GHRH
|
[NCBI]
|
1.47308e-05
|
|
|
GCKR
|
[NCBI]
|
1.45705e-05
|
|
|
CCKBR
|
[NCBI]
|
1.45705e-05
|
|
|
SDC3
|
[NCBI]
|
1.45705e-05
|
|
|
HTR2C
|
[NCBI]
|
1.45705e-05
|
|
|
LCN2
|
[NCBI]
|
1.44459e-05
|
|
|
IAPP
|
[NCBI]
|
1.42101e-05
|
|
|
IL6
|
[NCBI]
|
1.41607e-05
|
|
|
CD36
|
[NCBI]
|
1.39697e-05
|
|
|
APOA5
|
[NCBI]
|
1.39311e-05
|
|
|
ASPN
|
[NCBI]
|
1.39311e-05
|
|
|
AR
|
[NCBI]
|
1.39262e-05
|
|
|
APOD
|
[NCBI]
|
1.35174e-05
|
|
|
MTTI
|
[NCBI]
|
1.33581e-05
|
|
|
CTSS
|
[NCBI]
|
1.33581e-05
|
|
|
PON2
|
[NCBI]
|
1.28395e-05
|
|
|
ARMD1
|
[NCBI]
|
1.26678e-05
|
|
|
ADD1
|
[NCBI]
|
1.23661e-05
|
|
|
TFPI
|
[NCBI]
|
1.23226e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.1931e-05
|
|
|
AQP7
|
[NCBI]
|
1.1931e-05
|
|
|
FSHB
|
[NCBI]
|
1.15287e-05
|
|
|
OGG1
|
[NCBI]
|
1.15287e-05
|
|
|
HGPS
|
[NCBI]
|
1.14141e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.11971e-05
|
|
|
TBX21
|
[NCBI]
|
1.11547e-05
|
|
|
APOA2
|
[NCBI]
|
1.11547e-05
|
|
|
IGFBP3
|
[NCBI]
|
1.11547e-05
|
|
|
CCKAR
|
[NCBI]
|
1.11547e-05
|
|
|
GGCX
|
[NCBI]
|
1.11547e-05
|
|
|
AVP
|
[NCBI]
|
1.08503e-05
|
|
|
PGF
|
[NCBI]
|
1.08056e-05
|
|
|
SCARB1
|
[NCBI]
|
1.08056e-05
|
|
|
MC3R
|
[NCBI]
|
1.08056e-05
|
|
|
ADRB1
|
[NCBI]
|
1.08056e-05
|
|
|
GPR24
|
[NCBI]
|
1.08056e-05
|
|
|
LCAT
|
[NCBI]
|
1.06661e-05
|
|
|
LDLR
|
[NCBI]
|
1.06185e-05
|
|
|
CMT1A
|
[NCBI]
|
1.05077e-05
|
|
|
GCG
|
[NCBI]
|
1.04785e-05
|
|
|
APOM
|
[NCBI]
|
1.04785e-05
|
|
|
GCK
|
[NCBI]
|
1.04577e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.02932e-05
|
|
|
COMP
|
[NCBI]
|
1.02284e-05
|
|
|
PAPPA
|
[NCBI]
|
1.01708e-05
|
|
|
ACACA
|
[NCBI]
|
9.88047e-06
|
|
|
IBD1
|
[NCBI]
|
9.67623e-06
|
|
|
GAD2
|
[NCBI]
|
9.60586e-06
|
|
|
HSD11B1
|
[NCBI]
|
9.60586e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
9.47905e-06
|
|
|
FLT1
|
[NCBI]
|
9.34543e-06
|
|
|
IL1RN
|
[NCBI]
|
9.0979e-06
|
|
|
GHSR
|
[NCBI]
|
9.0979e-06
|
|
|
GHRHR
|
[NCBI]
|
9.0979e-06
|
|
|
AHO
|
[NCBI]
|
8.72955e-06
|
|
|
PMM2
|
[NCBI]
|
8.63715e-06
|
|
|
LRP5
|
[NCBI]
|
8.4221e-06
|
|
|
HK1
|
[NCBI]
|
8.4221e-06
|
|
|
PPARGC1A
|
[NCBI]
|
8.01879e-06
|
|
|
AHSG
|
[NCBI]
|
8.01879e-06
|
|
|
PTPN1
|
[NCBI]
|
8.01879e-06
|
|
|
NOS2A
|
[NCBI]
|
7.47169e-06
|
|
|
KCNJ11
|
[NCBI]
|
7.30272e-06
|
|
|
INSR
|
[NCBI]
|
7.06611e-06
|
|
|
ADM
|
[NCBI]
|
7.02118e-06
|
|
|
FASN
|
[NCBI]
|
6.98244e-06
|
|
|
AMH
|
[NCBI]
|
6.97924e-06
|
|
|
PD
|
[NCBI]
|
6.7964e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
6.57768e-06
|
|
|
EPHX1
|
[NCBI]
|
6.5411e-06
|
|
|
NTRK2
|
[NCBI]
|
6.40328e-06
|
|
|
PON1
|
[NCBI]
|
6.39984e-06
|
|
|
ALDH2
|
[NCBI]
|
6.26968e-06
|
|
|
FFI
|
[NCBI]
|
5.99677e-06
|
|
|
MMP3
|
[NCBI]
|
5.65815e-06
|
|
|
CRC
|
[NCBI]
|
5.63299e-06
|
|
|
ABCA1
|
[NCBI]
|
5.12575e-06
|
|
|
ERBB2
|
[NCBI]
|
5.12575e-06
|
|
|
RNASE3
|
[NCBI]
|
5.11193e-06
|
|
|
BDNF
|
[NCBI]
|
5.01875e-06
|
|
|
ABCG2
|
[NCBI]
|
4.93693e-06
|
|
|
FGF23
|
[NCBI]
|
4.93131e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
4.72539e-06
|
|
|
FRAP1
|
[NCBI]
|
4.64549e-06
|
|
|
XDH
|
[NCBI]
|
4.42366e-06
|
|
|
CEL
|
[NCBI]
|
4.16246e-06
|
|
|
SLC2A2
|
[NCBI]
|
4.16246e-06
|
|
|
SMS
|
[NCBI]
|
4.13086e-06
|
|
|
SST
|
[NCBI]
|
4.04841e-06
|
|
|
MMP9
|
[NCBI]
|
4.01174e-06
|
|
|
NOS3
|
[NCBI]
|
3.93877e-06
|
|
|
FMF
|
[NCBI]
|
3.91443e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.86732e-06
|
|
|
BTC
|
[NCBI]
|
3.72881e-06
|
|
|
BCL2
|
[NCBI]
|
3.66165e-06
|
|
|
NMU
|
[NCBI]
|
3.59584e-06
|
|
|
LIPC
|
[NCBI]
|
3.59584e-06
|
|
|
GPT
|
[NCBI]
|
3.53134e-06
|
|
|
BBS
|
[NCBI]
|
3.513e-06
|
|
|
IL10
|
[NCBI]
|
3.28565e-06
|
|
|
H6PD
|
[NCBI]
|
3.22714e-06
|
|
|
DRD4
|
[NCBI]
|
3.22714e-06
|
|
|
ADA
|
[NCBI]
|
3.2077e-06
|
|
|
MTTL1
|
[NCBI]
|
2.84684e-06
|
|
|
MTR
|
[NCBI]
|
2.74682e-06
|
|
|
AD
|
[NCBI]
|
2.71667e-06
|
|
|
factor v deficiency
|
[NCBI]
|
2.69813e-06
|
|
|
MTHFR
|
[NCBI]
|
2.65029e-06
|
|
|
RA
|
[NCBI]
|
2.3044e-06
|
|
|
SPP1
|
[NCBI]
|
2.27241e-06
|
|
|
PTGS2
|
[NCBI]
|
1.95059e-06
|
|
|
PAEP
|
[NCBI]
|
1.95059e-06
|
|
|
IL4
|
[NCBI]
|
1.91525e-06
|
|
|
GNRH1
|
[NCBI]
|
1.67929e-06
|
|
|
GAPDH
|
[NCBI]
|
1.53895e-06
|
|
|
MAOA
|
[NCBI]
|
1.53251e-06
|
|
|
AS
|
[NCBI]
|
1.46618e-06
|
|
|
PRL
|
[NCBI]
|
1.41409e-06
|
|
|
CFH
|
[NCBI]
|
1.31467e-06
|
|
|
PF4
|
[NCBI]
|
1.30646e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.23093e-06
|
|
|
CNTF
|
[NCBI]
|
1.10255e-06
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.05125e-06
|
|
|
WBS
|
[NCBI]
|
9.4537e-07
|
|
|
PMCH
|
[NCBI]
|
9.39979e-07
|
|
|
KDR
|
[NCBI]
|
9.12954e-07
|
|
|
GAL
|
[NCBI]
|
7.64034e-07
|
|
|
BGLAP
|
[NCBI]
|
7.50539e-07
|
|
|
SLC2A4
|
[NCBI]
|
5.8113e-07
|
|
|
PGR
|
[NCBI]
|
2.74279e-07
|
|
|
PEDF
|
[NCBI]
|
1.90943e-07
|
|
|
LRP1
|
[NCBI]
|
1.85103e-07
|
|
|
CP
|
[NCBI]
|
1.61279e-07
|
|
|
COMT
|
[NCBI]
|
1.47039e-07
|
|
|
ACP5
|
[NCBI]
|
1.3215e-07
|
|
|
BCHE
|
[NCBI]
|
1.13941e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.06279e-07
|
|
|
SOD2
|
[NCBI]
|
8.91908e-08
|
|
|
RTT
|
[NCBI]
|
5.46646e-08
|
|
|
HP
|
[NCBI]
|
5.27872e-08
|
|
|
phenylketonuria
|
[NCBI]
|
4.07311e-08
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.06734e-08
|
|
|
SOD1
|
[NCBI]
|
1.52149e-08
|
|
|
GHR
|
[NCBI]
|
1.22285e-08
|
|
|
TTR
|
[NCBI]
|
4.48023e-09
|
|
|
F3
|
[NCBI]
|
3.43469e-09
|
|
|
AKR1B1
|
[NCBI]
|
2.27075e-09
|
|